Aspen Pharmacare Holdings Profit Margin

The latest profit margin for APNHY is 1.97% as of June 2026. That compares with 9.85% in the prior-year period — down 80.0% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside Aspen Pharmacare Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, APNHY's profit margin moved from 9.85% to 1.97% — a 80.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aspen Pharmacare Holdings's valuation or profitability profile.

Against Healthcare companies, APNHY currently prints 1.97% for profit margin, while the sector average sits near 19.13%. That is roughly 89.7% below the sector mean. Large gaps often invite a closer look at Aspen Pharmacare Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Aspen Pharmacare Holdings converts resources into returns. At 1.97%, APNHY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 9.85% in the prior-year period — down 80.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting APNHY's profit margin (1.97%), review year-over-year change from 9.85%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.